flow trial semaglutide nejm Oral and Cardiovascular Outcomes in Patients with Type 2 Diabetes semaglutide cv outcomes 🔴Cardiovascular with

Always talk to your prescriber before changing medication or diet

The government group in charge of medicine safety, the FDA, has made new rules

The decreased levels of GSH and increased oxidative stress trigger endothelial damage, decreasing endothelial NO, which activates NF- B, ultimately increasing production of prothrombotic adhesion molecules

A.AliM.ShukatR.HanifS.HassanM.et al (2024)

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

The uncomfortable truth, though, is that none of this matters much if you can't afford the drugs